Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics

Since coronavirus disease 2019 (COVID-19) is a serious new worldwide public health crisis with significant morbidity and mortality, effective therapeutic treatments are urgently needed. Drug repurposing is an efficient and cost-effective strategy with minimum risk for identifying novel potential tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dan-Yang, Liu, Jia-Chen, Liang, Shuang, Meng, Xiang-He, Greenbaum, Jonathan, Xiao, Hong-Mei, Tan, Li-Jun, Deng, Hong-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069812/
https://www.ncbi.nlm.nih.gov/pubmed/33919660
http://dx.doi.org/10.3390/pharmaceutics13040545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069812/
https://www.ncbi.nlm.nih.gov/pubmed/33919660
http://dx.doi.org/10.3390/pharmaceutics13040545

Ejemplares similares